Arbutus Biopharma Corporation
ABUS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,742 | $2,523 | -$24,526 | -$12,532 |
| Dep. & Amort. | $11 | $11 | $330 | $333 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,263 | $864 | $3,564 | $1,632 |
| Change in WC | $1,150 | -$18,240 | $5,269 | -$229 |
| Other Non-Cash | -$499 | -$907 | $1,972 | $481 |
| Operating Cash Flow | -$5,817 | -$15,749 | -$13,391 | -$10,315 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $9 | $0 | -$86 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$51,300 | -$28,498 | -$34,716 | -$43,191 |
| Inv. Sales/Matur. | $41,281 | $44,100 | $46,065 | $56,688 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$10,019 | $15,611 | $11,349 | $13,411 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $844 | $453 | $2,784 | $1,422 |
| Financing Cash Flow | $844 | $453 | $2,784 | $1,421 |
| Forex Effect | -$12 | $21 | $4 | -$33 |
| Net Chg. in Cash | -$15,004 | $336 | $746 | $4,484 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37,412 | $37,076 | $36,330 | $31,846 |
| End Cash | $22,408 | $37,412 | $37,076 | $36,330 |
| Free Cash Flow | -$5,817 | -$15,749 | -$13,391 | -$10,401 |